» Authors » Sara E F Kost

Sara E F Kost

Explore the profile of Sara E F Kost including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 10
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kost S, Saleh A, Brown J, Yuan S, Kuzio B, Yang Dr L, et al.
Blood Adv . 2025 Feb; PMID: 39969198
No abstract available.
2.
Kost S, Saleh A, Yuan S, Kuzio B, Gibson S, Yang L, et al.
Blood Cancer J . 2023 Jan; 13(1):20. PMID: 36707503
No abstract available.
3.
Kost S, Saleh A, Mejia E, Mostafizar M, Bouchard E, Banerji V, et al.
Cancers (Basel) . 2019 Oct; 11(10). PMID: 31601046
The phosphatidyl-inositol 3 kinase (PI3K) δ inhibitor, idelalisib (IDE), is a potent inhibitor of the B-cell receptor pathway and a novel and highly effective agent for the treatment of chronic...
4.
Yang L, Kost S, Beiggi S, Zhang Y, Schmidt R, Nugent Z, et al.
Leuk Res . 2019 Sep; 86:106220. PMID: 31499418
No abstract available.
5.
Ishdorj G, Kost S, Beiggi S, Zang Y, Gibson S, Johnston J
Leuk Res . 2017 Jun; 59:66-74. PMID: 28575699
The shelterin proteins play important roles in telomere maintenance and genome stability. These proteins have been found to be mutated in many cancers including CLL. Herein, we demonstrate here the...
6.
Kost S, Bouchard E, LaBossiere E, Ye X, Queau M, Liang W, et al.
Leuk Res . 2016 Sep; 50:63-71. PMID: 27683974
Bendamustine (BEN) has structural similarities to an alkylating agent and a nucleoside analog, and effective against tumor cells that are resistant to standard therapy. In this study we compared the...